Back
Palisade Bio, Inc. PALI · Insights
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, engages in developing oral phosphodi... Price1.19
Market Cap252.39 M
Float210.53 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro